Ticker >

Krsnaa Diagnostics share price

Krsnaa Diagnostics Ltd.

NSE: KRSNAA BSE: 543328 SECTOR: Hospital & Healthcare Services  112k   222   53

593.70
-4.45 (-0.74%)
NSE: Today, 03:52 PM

Price Summary

Today's High

₹ 600

Today's Low

₹ 572.6

52 Week High

₹ 767.9

52 Week Low

₹ 448.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1917.04 Cr.

Enterprise Value

1841.32 Cr.

No. of Shares

3.23 Cr.

P/E

36.9

P/B

2.48

Face Value

₹ 5

Div. Yield

0.46 %

Book Value (TTM)

₹  239.86

CASH

108.21 Cr.

DEBT

32.48 Cr.

Promoter Holding

27.03 %

EPS (TTM)

₹  16.09

Sales Growth

2.02%

ROE

8.92 %

ROCE

11.96%

Profit Growth

-10.17 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.02%
3 Year21.55%
5 Year38.65%

Profit Growth

1 Year-10.17%
3 Year36.93%
5 Year67.18%

ROE%

1 Year8.92%
3 Year9.97%
5 Year5.98%

ROCE %

1 Year11.96%
3 Year53.07%
5 Year-22.01%

Debt/Equity

0.0439

Price to Cash Flow

25.4

Interest Cover Ratio

11.6977743069114

CFO/PAT (5 Yr. Avg.)

2.80908987279811

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 27.03 0
Dec 2023 27.03 0
Sep 2023 27.8 0
Jun 2023 27.8 0
Mar 2023 27.8 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 36.9278543448262% for the Past 3 years.
  • The company has shown a good revenue growth of 21.5490989573208% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 53.067143387926% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 11.6977743069114.
  • The company has an efficient Cash Conversion Cycle of -267.432150197307 days.
  • Company has a healthy liquidity position with current ratio of 2.37892913385827.
  • The company has a good cash flow management; CFO/PAT stands at 2.80908987279811.

 Limitations

  • The company has a low EBITDA margin of 3.5700404149599% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 115.74 115.86 132.29 146.85 151.55
Total Expenditure 81.96 90.76 100.1 114.31 113.39
Operating Profit 33.78 25.1 32.18 32.55 38.16
Other Income 4.55 5.94 4.22 4.16 4.08
Interest 2.26 2.23 1.95 3.06 4.14
Depreciation 13.9 14.6 15.74 19.46 21.23
Exceptional Items 0 0 0 0 0
Profit Before Tax 22.17 14.2 18.72 14.18 16.87
Tax 5.3 2.39 3.47 2.88 3.28
Profit After Tax 16.87 11.81 15.25 11.31 13.59
Adjusted EPS (Rs) 5.37 3.76 4.86 3.6 4.21

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 209.24 258.43 396.46 454.89 464.08
Total Expenditure 246.83 372.64 302.65 320.34 339.84
Operating Profit -37.6 -114.21 93.81 134.55 124.25
Other Income 5.08 12.95 265.02 14.93 19.41
Interest 19.57 24.66 25.94 18.49 7.68
Depreciation 25.64 32.41 37.44 41.39 53.78
Exceptional Items 0 0 0 0 0
Profit Before Tax -77.73 -158.33 295.45 89.6 82.19
Tax -19.67 -46.38 110.52 18.9 18.68
Net Profit -58.06 -111.95 184.93 70.7 63.51
Adjusted EPS (Rs.) -56.22 -108.42 142.36 22.52 20.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 20.19 20.19 248.89 15.7 15.7
Total Reserves -105.11 -217.16 -17.02 671.05 726.8
Borrowings 92.02 122.71 167.95 33.07 24.28
Other N/C liabilities 304.98 431.28 20.91 37.59 47.35
Current liabilities 173.32 180.8 188.55 119.64 95.25
Total Liabilities 485.4 537.81 609.28 877.06 909.38
Assets
Net Block 223.09 275.1 308.51 385.69 470.68
Capital WIP 41.66 9.13 3.72 28.26 25.48
Intangible WIP 0.13 0 0 0 0
Investments 0.29 0.29 0.29 0.36 0.36
Loans & Advances 13.84 28.16 33.83 17.87 26.37
Other N/C Assets 17.81 11.51 10.04 109.11 159.91
Current Assets 188.59 213.63 252.89 335.77 226.59
Total Assets 485.4 537.81 609.28 877.06 909.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -77.73 -158.33 295.45 89.6 82.19
Adjustment 139.61 225.66 -198.74 49.2 44.79
Changes in Assets & Liabilities 3.37 -19.32 29.62 -3.46 -38.37
Tax Paid -6.99 -10.2 -7.67 -6.63 -13.13
Operating Cash Flow 58.27 37.81 118.66 128.71 75.48
Investing Cash Flow -199.25 -76.65 -67.37 -241.1 -108.54
Financing Cash Flow 124.27 5.78 20.03 176.04 -33.13
Net Cash Flow -16.72 -33.06 71.32 63.65 -66.19

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 27.80 27.80 27.80 27.03 27.03
krsna diagnostics (mumbai... 2.22 2.22 2.22 2.16 2.16
rajendra khivraj mutha 25.57 25.57 25.57 24.87 24.87
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 72.20 72.20 72.20 72.97 72.97
aditya birla sun life ins... 3.99 3.99 2.05 1.69 1.36
cybage software private l... - - - - 1.00
hdfc life insurance compa... 1.82 1.82 1.98 1.93 1.93
icici prudential pharma h... 5.10 5.30 - 3.70 2.73
k india opportunities fun... - - - - 2.19
kirankumar prabhakar bhis... 1.38 1.50 1.47 1.41 1.52
kitara piin 1104 3.55 3.55 3.55 2.95 1.26
phi capital trust - phi c... 15.88 15.88 15.88 15.44 15.44
tata mutual fund - tata s... 5.26 6.02 6.59 7.40 7.40
acm global fund vcc - 2.62 2.62 2.00 -
icici prudential smallcap... - - 5.40 - -
inevsco india smallcap fu... - 1.03 1.30 - -
medimaze solutions privat... - - 1.75 - -
hsbc global investment fu... 1.22 1.03 - - -
techjivaa software privat... 1.75 1.75 - - -
somerset indus healthcare... 2.84 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Krsnaa Diagnostics incorporates wholly owned subsidiary9 Apr 2024, 3:26PM Krsnaa Diagnostics informs about newspaper publication 6 Mar 2024, 12:33PM Krsnaa Diagnostics informs about analyst meet5 Mar 2024, 5:30PM Krsnaa Diagnostics informs about notice of postal ballot5 Mar 2024, 12:31PM Krsnaa Diagnostics informs about investors meet23 Feb 2024, 2:43PM Krsnaa Diagnostics submits analyst meet intimation23 Feb 2024, 12:32PM Krsnaa Diagnostics informs about analyst meet20 Feb 2024, 3:27PM Krsnaa Diagnostics informs about resignation of managing director13 Feb 2024, 10:02AM Krsnaa Diagnostics informs about grant of options under ESOS13 Feb 2024, 9:56AM Krsnaa Diagnostics informs about incorporation of WOS13 Feb 2024, 9:55AM Krsnaa Diagnostics gets nod to incorporate wholly owned subsidiary13 Feb 2024, 9:48AM Krsnaa Diagnostics - Quaterly Results12 Feb 2024, 10:01PM Krsnaa Diagnostics - Quaterly Results12 Feb 2024, 10:01PM Krsnaa Diagnostics bags contract to provide MRI, CT Scan Services in Maharashtra30 Jan 2024, 11:28AM Krsnaa Diagnostics informs about analyst meet18 Jan 2024, 2:28PM Krsnaa Diagnostics informs about disclosure1 Jan 2024, 4:40PM Krsnaa Diagnostics submits Disclosure 9 Dec 2023, 2:49PM Krsnaa Diagnostics submits analyst meet intimation4 Dec 2023, 4:55PM Krsnaa Diagnostics submits analyst meet intimation30 Nov 2023, 4:33PM Krsnaa Diagnostics informs about analyst meet 28 Nov 2023, 3:02PM Krsnaa Diagnostics informs about allotment of equity shares ESOS28 Nov 2023, 3:01PM Krsnaa Diagnostics informs about analyst meet24 Nov 2023, 4:28PM Krsnaa Diagnostics informs about monitoring agency report9 Nov 2023, 4:06PM Krsnaa Diagnostics - Quaterly Results3 Nov 2023, 6:28PM Krsnaa Diagnostics - Quaterly Results3 Nov 2023, 6:28PM Krsnaa Diagnostics informs about newspaper publication4 Sep 2023, 4:42PM Krsnaa Diagnostics submits AGM notice and annual report 2 Sep 2023, 2:38PM Krsnaa Diagnostics informs about newspaper publications28 Aug 2023, 3:27PM Krsnaa Diagnostics submits analyst meet intimation19 Aug 2023, 4:28PM Krsnaa Diagnostics informs about newspaper publication14 Aug 2023, 4:11PM Krsnaa Diagnostics - Quaterly Results12 Aug 2023, 7:43PM Krsnaa Diagnostics - Quaterly Results12 Aug 2023, 7:43PM Krsnaa Diagnostics informs about appointment of CO24 Jul 2023, 1:48PM Krsnaa Diagnostics informs about compliance certificate5 Jul 2023, 5:12PM Krsnaa Diagnostics informs about transcript of earning call 3 Jun 2023, 3:03PM Krsnaa Diagnostics informs about audio recording of earnings call 30 May 2023, 5:13PM Krsnaa Diagnostics - Quaterly Results27 May 2023, 8:42PM Krsnaa Diagnostics - Quaterly Results27 May 2023, 8:42PM Krsnaa Diagnostics commences CT Scan Services at Municipal General Hospital in Ghatkoper8 May 2023, 3:57PM Krsnaa Diagnostics commences fourth Diagnostics Center at Ayodhya8 May 2023, 3:16PM Krsnaa Diagnostics qualified as L1 Bidder for tender issued by National Health Mission, Assam2 May 2023, 12:50PM Krsnaa Diagnostics receives Tender from Mira-Bhayandar Municipal Corporation, Thane17 Apr 2023, 2:55PM Krsnaa Diagnostics bags additional order from BMC 11 Apr 2023, 12:59PM Krsnaa Diagnostics informs about disclosure24 Mar 2023, 2:33PM Krsnaa Diagnostics emerges as L1 bidder to provide laboratory services in Rajasthan20 Mar 2023, 2:23PM Krsnaa Diagnostics informs about award of order20 Mar 2023, 2:07PM Krsnaa Diagnostics operationalizes 100 more pathology collection centers in Mumbai14 Mar 2023, 10:58AM Krsnaa Diagnostics operationalizes 100 more pathology collection centers in Mumbai10 Mar 2023, 11:18AM Krsnaa Diagnostics informs about commencement of operations9 Mar 2023, 5:02PM Krsnaa Diagnostics informs about disclosure6 Mar 2023, 4:41PM

Krsnaa Diagnostics Stock Price Analysis and Quick Research Report. Is Krsnaa Diagnostics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Krsnaa Diagnostics and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Krsnaa Diagnostics cash from the operating activity was Rs 75.483 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Krsnaa Diagnostics has a Debt to Equity ratio of 0.0439 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Krsnaa Diagnostics , the EPS growth was -10.1748355781742 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Krsnaa Diagnostics has OPM of 26.7723661500206 % which is a good sign for profitability.
     
  • ROE: Krsnaa Diagnostics have a poor ROE of 8.91637207029879 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Krsnaa Diagnostics is Rs 593.7. One can use valuation calculators of ticker to know if Krsnaa Diagnostics share price is undervalued or overvalued.
Last Updated on:
Brief about Krsnaa Diagnostics

Krsnaa Diagnostics Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Krsnaa Diagnostics Ltd. is a leading diagnostics service provider in India. With a strong presence in both urban and rural areas, the company is committed to providing high-quality diagnostic services to its customers. Krsnaa Diagnostics offers a wide range of diagnostic services including pathology, radiology, imaging, and tele-radiology services.

The company has a well-established network of diagnostic centers and offers its services through a hub-and-spoke model, allowing it to reach a larger customer base. Krsnaa Diagnostics is known for its state-of-the-art infrastructure, advanced technology, and highly skilled professionals.

Krsnaa Diagnostics Ltd. - Share Price

Investors interested in Krsnaa Diagnostics Ltd. can keep track of its share price on our website. We provide real-time updates on the stock's performance, allowing investors to make informed decisions. Our website also offers pre-built screening tools that enable investors to analyze the company's share price over different time periods and compare it to industry peers.

Krsnaa Diagnostics Ltd. - Balance Sheet

The balance sheet of Krsnaa Diagnostics Ltd. provides a snapshot of the company's financial position. Investors can access the company's annual reports on our website, which include detailed information about its assets, liabilities, and shareholders' equity. For a comprehensive analysis, our premium features allow fair value calculation through tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Krsnaa Diagnostics Ltd. - Annual Report

Krsnaa Diagnostics Ltd. releases its annual reports on our website, which provide a comprehensive overview of the company's performance throughout the year. These reports include valuable information about the company's financial statements, business operations, growth prospects, and future plans. Investors can download these reports to gain insights and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Dividend

Investors interested in dividends can find information about Krsnaa Diagnostics Ltd.'s dividend payments on our website. We provide updates on the company's dividend history, including the amount paid and the dividend yield. Investors can use this information to assess the company's dividend policy and evaluate its potential as an income-generating investment.

Krsnaa Diagnostics Ltd. - Quarterly Result

Tracking Krsnaa Diagnostics Ltd.'s quarterly results is essential for investors. Our website offers quarterly result updates, allowing investors to stay informed about the company's financial performance and analyze trends over time. Our premium features enable investors to conduct in-depth analysis and calculate the fair value of the stock using various tools.

Krsnaa Diagnostics Ltd. - Stock Price

Our website provides real-time updates on Krsnaa Diagnostics Ltd.'s stock price. Investors can track the stock's performance and view price charts to identify patterns or trends. We also offer pre-built screening tools to analyze the stock price and compare it to industry peers, helping investors make informed investment decisions.

Krsnaa Diagnostics Ltd. - Price Chart

Monitoring the price chart of Krsnaa Diagnostics Ltd.'s stock is crucial for investors. Our website offers interactive price charts that provide a visual representation of the stock's performance over different time periods. Investors can use these charts to identify historical price patterns and make predictions about future price movements.

Krsnaa Diagnostics Ltd. - News

Stay updated with the latest news about Krsnaa Diagnostics Ltd. on our website. We provide timely news updates related to the company's business operations, financial performance, strategic partnerships, and other relevant events. Investors can access these news articles to stay informed and make well-informed investment decisions.

Krsnaa Diagnostics Ltd. - Concall Transcripts

Investors interested in gaining insights from Krsnaa Diagnostics Ltd.'s investor conference calls can access the transcripts on our website. These transcripts provide a verbatim record of the discussions and presentations during the conference calls. Investors can refer to these transcripts for detailed information about the company's strategy, financial performance, and future outlook.

Krsnaa Diagnostics Ltd. - Investor Presentations

Krsnaa Diagnostics Ltd. provides investor presentations on our website. These presentations offer valuable insights into the company's business model, growth prospects, and financial performance. Investors can download these presentations to gain a deeper understanding of the company and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Promoters

Krsnaa Diagnostics Ltd. has a dedicated team of promoters who have played a vital role in the company's growth and success. Our website provides information about the promoters, their backgrounds, and their contributions to the company. Knowing about the promoters can help investors gauge the company's leadership and their commitment to long-term growth.

Krsnaa Diagnostics Ltd. - Shareholders

Understanding the company's shareholders is crucial for investors. Our website provides information about Krsnaa Diagnostics Ltd.'s major shareholders, including institutional investors and individual investors. Investors can analyze the shareholding pattern to assess the confidence of other investors in the company and make informed investment decisions.

Remember, you can find additional tools and resources on our website, such as annual reports, concall transcripts, investor presentations, credit ratings, and research reports, to support your stock analysis. We aim to provide comprehensive information and analysis that will be valuable to long-term stock investors.

Read More
X